Skip to content

The treatment of patients with ureteral endometriosis in the real-world clinical practice

The treatment of patients with ureteral endometriosis in the real-world clinical practice

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074336
Enrollment
Unknown
Registered
2023-08-03
Start date
2023-06-13
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Ureteral endometriosis treated by surgery and/or medication group:None

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Patients who signed written informed consent and agreed to be enrolled; 2.Women of childbearing age, between 20-45 years; 3.According to the Guideline for Diagnosis and Treatment of Endometriosis (3rd Edition), the patient is diagnosed with endometriosis by clinical or surgical pathology; 4.Outpatient ultrasonography or CTU/MRU indicating ureter dilation (diameter = 0.6cm) or ureteral endometriosis found during operation;

Exclusion criteria

Exclusion criteria: 1.Patients who did not meet the inclusion criteria; 2.Patients participating in other intervention studies besides routine clinical treatment; 3.Patients with poor living conditions, incapacitation or loss of consciousness; 4.Patients who refused to participate in the study; 5.Patients with concomitant or diagnosed malignant tumor 6.Combined with other diseases of urinary system or a history of urinary system surgery; 7.There are other causes of urinary obstruction; 8.Renal hemogram indicated that renal function on the affected side had been lost, but could not be recovered after drainage.

Design outcomes

Primary

MeasureTime frame
Health-related quality of life;

Secondary

MeasureTime frame
Rate of ureteral obstruction remission and weather combined with hydronephrosis;Serum creatinine;Blood pressure;Renal hemogram;Computed Tomography Urography/Magnetic Resonance Urography/Intravenous Pyelography[CTU/MRU/IVP (one of three)];Urinary symptoms assessment;Dysmenorrhea, dyspareunia, and chronic pelvic pain;Patient Global Impressions-Change;

Countries

China

Contacts

Public ContactYi Dai

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

jacquedai@vip.sina.com+86 186 1102 7788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026